Secondary Lymphedema

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Novo Nordisk
Novo NordiskBAGSVAERD DENMARK, Denmark
1 program
Indocyanine GreenN/A1 trial
Active Trials
NCT03572998Unknown28Est. Aug 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Novo NordiskIndocyanine Green

Clinical Trials (1)

Total enrollment: 28 patients across 1 trials

NCT03572998Novo NordiskIndocyanine Green

Lymphatic Function in Patients Who Have Undergone Breast Cancer Treatment

Start: Sep 2018Est. completion: Aug 201928 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space